[Role of EZH2 Inhibitor Combined with Gefitinib in EGFR-TKIs Resistant Lung Cancer Cells].
Gong H, Yuan Y, Li Y, Zhang H, Li Y, Li W, Wang P, Shi R, Liu C, Cui L, Liu H, Chen J.
Gong H, et al.
Zhongguo Fei Ai Za Zhi. 2019 May 20;22(5):255-263. doi: 10.3779/j.issn.1009-3419.2019.05.01.
Zhongguo Fei Ai Za Zhi. 2019.
PMID: 31109434
Free PMC article.
Chinese.